Related Experiment Video
Updated: Jul 2, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
The Long-Term Survival of LVAD Patients-A TriNetX Database Analysis
Nandini Nair1, Balakrishnan Mahesh2, Dongping Du3
1Department of Medicine, Division of Cardiology, Penn State Health/PSUCOM, 500 University Drive, Hershey, PA 17033, USA.
Long-term survival for patients with continuous-flow left ventricular assist devices (CF-LVADs) is impacted by various factors. Identifying these risks, such as infections and comorbidities, can improve patient outcomes.
Area of Science:
- Cardiology
- Medical Devices
- Public Health
Background:
- Heart transplantation is limited by donor availability, increasing reliance on continuous-flow left ventricular assist devices (CF-LVADs) for end-stage heart failure.
- Long-term survival data for CF-LVAD recipients is crucial for managing end-stage heart failure.
- Investigating factors influencing long-term outcomes in CF-LVAD patients is essential.
Purpose of the Study:
- To assess the impact of demographics, infections, comorbidities, cardiomyopathies, arrhythmias, and end-organ dysfunction on long-term survival in CF-LVAD recipients.
- To identify specific risk factors and potential protective elements affecting survival post-LVAD implantation.
- To provide a comprehensive long-term survival analysis for the CF-LVAD population.
Main Methods:
- Utilized the TriNetX de-identified patient database for comprehensive data analysis.
- Employed log-rank tests to evaluate post-implant survival.
- Conducted univariate Cox regression analysis to determine Hazard Ratios (HR) for various factors, using Python and the lifelines library.
Main Results:
- Identified Cytomegalovirus (CMV), hepatitis A exposure, atrial fibrillation, paroxysmal ventricular tachycardia, ischemic cardiomyopathy, renal dysfunction, diabetes, COPD, mitral valve disease, and essential hypertension as significant risk factors for long-term survival.
- Observed a potentially protective effect of hypokalemia on long-term survival.
- Found no significant impact of gender on long-term survival outcomes.
Conclusions:
- This study provides the first detailed long-term survival assessment of the CF-LVAD population utilizing a de-identified database.
- Specific infections, comorbidities, and end-organ dysfunction significantly influence long-term survival in CF-LVAD recipients.
- Further research into the protective mechanisms of hypokalemia and mitigation strategies for identified risk factors is warranted.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021